Form 4: Senseonics Chief Medical Officer Adjusts Stock Holdings for Tax Obligations
Insider Transaction Report
Senseonics Holdings, Inc. Director and Chief Medical Officer Francine Kaufman reported a disposition of 28,853 common shares to cover tax obligations related to restricted stock unit vesting.
Summary
- Francine Kaufman, a Director and the Chief Medical Officer of Senseonics Holdings, Inc. (SENS), filed a Form 4 detailing a change in her beneficial ownership.
- On June 16, 2025, Ms. Kaufman disposed of 28,853 common shares.
- This disposition was made to satisfy withholding tax obligations upon the vesting of restricted stock units.
- The shares were valued at $0.51 per share for the purpose of this tax withholding.
- Following this transaction, Ms. Kaufman directly beneficially owns 2,571,057 common shares of Senseonics Holdings, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction related to executive compensation and tax obligations, not indicative of operational performance or strategic shifts.
Positives
- The transaction represents the vesting of restricted stock units, which is a positive event for the executive as it signifies the realization of compensation.
- The disposition of shares is a routine, non-discretionary event to cover tax liabilities, indicating a standard compensation process rather than a sale driven by a change in sentiment.
Negatives
- The reported transaction involves a reduction in the number of shares directly held by the insider, although this is for tax purposes and not a discretionary sale.
Future Outlook
This Form 4 filing is a transactional report of insider stock ownership changes and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This document is a standard SEC Form 4 filing, which reports changes in beneficial ownership by company insiders. It does not provide information related to broader industry trends or competitors, as its scope is limited to a specific insider's stock transaction.
Stakeholder Impact
- Shareholders: Minimal direct impact, as this is a routine tax-related transaction for an insider's compensation. It does not reflect a change in company fundamentals or strategy.
- Employees: No direct impact on general employees, but it reflects standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 06/16/2025 | Date of transaction where 28,853 common shares were disposed of to satisfy withholding tax obligations. |
| 06/17/2025 | Date the Form 4 filing was signed by the attorney-in-fact for Francine Kaufman. |
Keywords
Senseonics Holdings, SENS, Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, Tax Withholding, Francine Kaufman, Chief Medical Officer, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.